Sittner & Nelson’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-99
Closed -$2.05K 450
2024
Q2
$2.05K Sell
99
-31
-24% -$616 ﹤0.01% 421
2024
Q1
$2.44K Sell
130
-82
-39% -$1.41K ﹤0.01% 433
2023
Q4
$3.06K Sell
212
-10
-5% -$136 ﹤0.01% 410
2023
Q3
$3.85K Sell
222
-15
-6% -$313 ﹤0.01% 401
2023
Q2
$4.93K Hold
237
﹤0.01% 405
2023
Q1
$5.57K Hold
237
﹤0.01% 400
2022
Q4
$6.62K Buy
237
+59
+33% +$1.51K ﹤0.01% 370
2022
Q3
$4K Sell
178
-12
-6% -$362 ﹤0.01% 395
2022
Q2
$6K Hold
190
﹤0.01% 406
2022
Q1
$7K Sell
190
-139
-42% -$4.75K ﹤0.01% 367
2021
Q4
$10K Sell
329
-39
-11% -$1.27K 0.01% 341
2021
Q3
$12K Buy
+368
New +$11.8K 0.01% 308

Other funds holding OGN

Sittner & Nelson's OGN Position: Q3 2024 in Review

Sittner & Nelson sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 99 shares — an estimated $2.05K sold.

Sittner & Nelson first reported a position in OGN in Q3 2021 and held it in 12 quarters. The position peaked at $12K in Q3 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Sittner & Nelson reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Sittner & Nelson sold 99 Organon & Co shares in Q3 2024, an estimated $2.05K.
  • Sittner & Nelson first reported a position in Organon & Co in Q3 2021 and held it in 12 quarters.
  • Sittner & Nelson's Organon & Co position peaked at $12K in Q3 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Sittner & Nelson's 13F filing for Q3 2024, filed 31 Oct 2024.